Company: MHLA
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0001412100-25-000011
Chunk: 105

Company: Maiden Holdings, Ltd.
Filing Date: 2025-03-10
Form: 10-K
Item: Item 5
Chunk 105
---
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 

Our common shares began publicly trading on the Nasdaq under the symbol "MHLD" on May 6, 2008 and our shares currently trade on the Nasdaq Capital Market. At March 3, 2025, the closing sale price of our common share was $0.82 per share and there were 18 holders of record of our common shares. This figure does not represent the actual number of beneficial owners of our common shares because shares are frequently held in "street name" by securities dealers and others for the benefit of beneficial owners who may vote the shares. 

No dividends have been declared by our Board on our common shares since the third quarter of 2018. The future declaration and payment of dividends to common shareholders will be at the discretion of our Board subject to specified legal, regulatory, financial and other restrictions. Please see "Notes to Consolidated Financial Statements - Note 15 — Statutory Requirements and Dividend Restrictions" under Item 8 "Financial Statements and Supplementary Data" of this Annual Report on Form 10-K for discussion regarding dividend restrictions on subsidiary's ability to transfer funds to Maiden Holdings.

On February 21, 2017, our Board approved the repurchase of up to $100.0 million of our common shares from time to time at market prices. For the year ended December 31, 2024, Maiden Reinsurance repurchased 1,871,755 common shares at an average price per share of $1.87 under our authorized share repurchase plan (2023 - 1,439,575 at an average price of $1.83 per share). The Company's remaining authorization for common share repurchases was $68.1 million at December 31, 2024 (December 31, 2023 - $71.6 million). No repurchases of common shares were made subsequent to December 31, 2024 and through the period ended March 10, 2025 under the Company's share repurchase authorization plan. In connection with the Combination Agreement entered into with Kestrel, Maiden has suspended its common share repurchase program.

During the year ended December 31, 2024, we repurchased a total of 127,555 (2023 - 128,731) common shares at an average price of $1.79 per share (2023 - $2.25) from employees, which